Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IBRX
#815
ImmunityBio, Inc. Common Stock
9.7
8
+3.93%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+3.93%
Mudança mensal
+63.00%
Mudança em 6 meses
+312.66%
Mudança anual
+213.46%
Fechamento anterior
9.4
1
Open
9.7
8
Bid
Ask
Low
9.7
8
High
9.7
8
Volume
189
Mercados
Ações
Cuidados de saúde
IBRX
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
109.34 M
397.91 M
435.84 M
673.95 M
853.44 M
1.03 B
—
Valuation ratios
Enterprise value
—
2.24 B
1.98 B
3.27 B
2.04 B
1.95 B
9.27 B
Price to earnings ratio
—
-6.83
-4.59
-4.56
-4.13
-5.21
-22.26
Price to sales ratio
—
2 533.77
7 948.02
4 284.97
121.61
16.08
155.25
Price to cash flow ratio
—
-8.62
-5.65
-7.27
-4.58
-5.97
-24.09
Price to book ratio
—
9.77
4.26
4.54
3.67
3.64
6.31
Enterprise value to EBITDA ratio
—
—
—
—
-6.25
25.23
-301.82
Profitability ratios
Return on assets %
0.61
0.74
1.15
1.16
1.08
0.7
0.91
Return on equity %
0.79
1.42
0.93
1
0.85
0.7
0.63
Return on invested capital %
406.3
499.16
255.34
327.6
630.3
482.51
477.01
Gross margin %
100
100
100
100
100
99.34
397.58
Operating margin %
82.55 K
35.36 K
146.37 K
58.24 K
2 334.23
226
1 002.3
EBITDA margin %
—
—
—
—
-2 215.18
68.17
308.16
Net margin %
83.23 K
37.13 K
173.57 K
93.76 K
2 804.77
310.18
1 506.74
Liquidity ratios
Quick ratio
—
—
—
—
3.21
5.08
16.76
Current ratio
3.06
0.91
0.28
5.05
3.36
5.1
17.19
Inventory turnover
—
—
—
—
0
0.16
0.15
Asset turnover
0
0
0
0
0.03
0.26
0.27
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
-0.18
1.66
0.74
0.65
2.99
Long term debt to total equity ratio
—
—
-0.14
1.43
0.58
0.65
2.29
Per share metrics
Operating cash flow per share
—
0.7
0.84
0.72
0.56
0.33
0.34
EBIT per share
—
—
—
—
-0.49
0.07
0.08
EBITDA per share
—
—
—
—
-0.47
0.08
0.1
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
0.81
0.27
0.52
0.21
0.26
0.78
Net current asset value per share
—
0.86
0.35
0.58
0.26
0.34
1.05
Tangible book value per share
—
0.62
1.07
1.12
0.68
0.53
2.37
Working capital per share
—
-0.09
-0.9
0.46
0.19
0.28
0.81
Book value per share
—
0.62
1.12
1.15
0.7
0.54
2.43
Notícias
Diretor Barry J. Simon vende ações da ImmunityBio (IBRX) no valor de US$ 900 mil
Simon, director, sells ImmunityBio (IBRX) shares worth $900k
ImmunityBio conclui recrutamento em estudo sobre câncer de bexiga
ImmunityBio completes enrollment in bladder cancer trial
ImmunityBio Investors Rally Behind Cancer Trial Milestone - ImmunityBio (NASDAQ:IBRX)
Netflix and Palantir among market cap stock movers on Wednesday
ImmunityBio Supersedes Expectations With Fivefold Revenue Increase - ImmunityBio (NASDAQ:IBRX)
Diretora da Immunitybio vende US$ 250.000 em ações
Barry J. Simon vende ações da ImmunityBio (IBRX) no valor de US$ 1,78 milhão
AMD and Keysight Technologies among market cap stock movers on Tuesday
Tesla, Oracle among market cap stock movers on Monday
H.C. Wainwright eleva preço-alvo das ações da Immunitybio para US$ 15